🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Obstructive lung disease is defined by limitations in expiratory airflow, c...
Status
Completed
Location
Shrewsbury and Telford hospital Trust
Start Date
2023-03-16
Trial ID
NCT05616780
Treatments Being Tested
Purpose of this study is to investigate the agreement, the test-retest reli...
Status
Unknown
Location
Institute for Ophthalmic Research, University of Tuebingen
Start Date
2011-03
Trial ID
NCT01312662
This is a prospective investigation which aims to address key challenges to...
Status
Completed
Location
University of Wisconsin
Start Date
2021-09-13
Trial ID
NCT04818060
Treatments Being Tested
Knee osteoarthritis (OA) is the most common form of arthritis and the most ...
Status
Completed
Location
The University of Nottingham, City Hospital Campus
Start Date
2020-11-06
Trial ID
NCT04443452
This is a Phase Ib, open-label, multiple-center, multiple-dose study design...
Status
Completed
Location
Multiple Locations
Start Date
2012-03
Trial ID
NCT01546519
Treatments Being Tested
Background: Primary immunodeficiency disorders, or PIDs, are diseases that...
Status
Recruiting
Location
Children's National Health System (CNHS)
Start Date
2018-05-30
Trial ID
NCT03394053
The goal of this clinical trial is to evaluate and compare the effectivenes...
Status
Completed
Location
Hospital Civil de Guadalajara Fray Antonio Alcalde
Start Date
2024-08-01
Trial ID
NCT06622512
Treatments Being Tested
The purpose of this study is to compare the efficacy and safety of Trabecto...
Status
Terminated
Location
Royal Alexandra Hospital
Start Date
2009-11
Trial ID
NCT00901108
Treatments Being Tested
This study aimed to detect the effects of remote ischemic conditioning on i...
Status
Completed
Location
Helwan University
Start Date
2022-09-01
Trial ID
NCT07272408
Treatments Being Tested
RATIONALE: Vandetanib may stop the growth of cancer cells by blocking some ...
Status
Completed
Location
Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office
Start Date
2008-03
Trial ID
NCT00734890
Treatments Being Tested